ask="1.2200"
ask_size="1000"
average_daily_volume="350568"
bid="1.1800"
bid_size="300"
book_value="0.6840"
change="-0.0125"
change_from_200_day_moving_average="0.1292"
change_from_50_day_moving_average="0.0978"
change_from_52_week_high="-0.2725"
change_From_52_week_low="0.4375"
change_in_percent="-1.0776%"
close="1.1475"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2730"
ebitda="-15.76M"
eps_estimate_current_year="-0.2800"
eps_estimate_next_quarter="-0.0500"
eps_estimate_next_year="-0.1800"
ex_dividend_date="N/A"
float_shares="44274000"
high="1.2000"
high_52_weeks="1.4200"
last_trade_date="2/28/2017"
last_trade_price="1.1475"
last_trade_size="100"
last_trade_time="3:59pm"
low="1.1300"
low_52_weeks="0.7100"
market_capitalization="64.76M"
moving_average_200_day="1.0183"
moving_average_50_day="1.0497"
name="BioLineRx Ltd."
notes="N/A"
one_year_target_price="2.3300"
open="1.1500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+12.6867%"
percent_change_from_50_day_moving_average="+9.3159%"
percent_change_from_52_week_high="-19.1901%"
percent_change_from_52_week_low="+61.6197%"
previous_close="1.1600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.6959"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="56432000"
short_ratio="0.4500"
stock_exchange="NCM"
symbol="BLRX"
volume="250506"
weeks_range_52="0.7100 - 1.4200"
